Drugs / ELAD System
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02612428 | Jan 2016 → Mar 2018 | alcoholic hepatitis | Vital Therapies, Inc. | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ELAD System | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02612428 ↗ |
| Modality | Cell therapy | “An extracorporeal human hepatic cell-based liver treatment” NCT02612428 ↗ |